DalsnaFinance › Analyst accuracy › Stifel › IMNM target
Stifel initiates Immunome stock coverage with Hold rating at $24
Stifel initiated coverage on Immunome Inc. (NASDAQ:IMNM) with a Hold rating and set a price target of $24.00.
A fact about what Stifel published, as reported by Investing.com, not a recommendation from Dalsna Finance; Stifel is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.